ArticleBMC cancer2025

The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer.

Peteris Loza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.